Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011–2012

Journal of Clinical Lipidology

Volumn 10, Issue 5, 2016, Pages 1109-1118

  Wong, Nathan D ^a   Young, Daphnee ^a   Zhao, Yanglu ^a   Nguyen, Huy ^a   Caballes, Jared ^a   Khan, Irfan ^b   Sanchez, Robert J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SANOFI   (France)

^c REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

Cardiovascular disease; Cholesterol; Dyslipidemia; Goal attainment; Guidelines; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SATURATED FATTY ACID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DIETARY COMPLIANCE; DRUG USE; ETHNICITY; FEMALE; GOAL ATTAINMENT; HEALTH SURVEY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; BLOOD; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; EXERCISE; MIDDLE AGED; NUTRITION; PRACTICE GUIDELINE; QUESTIONNAIRE; RISK;

ADULT; AMERICAN HEART ASSOCIATION; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIFE STYLE; MALE; MIDDLE AGED; NUTRITION SURVEYS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RISK; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 84995684252     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2016.06.011     Document Type: Article

References (27)

1. 1 Cholesterol Treatment Trialists’ (CTT) Collaboration, Baigent, C., Blackwell, L., Emberson, J., et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376 (2010), 1670–1681.
2. 2 Cholesterol Treatment Trialists' (CTT) Collaborators, Kearney, P.M., Blackwell, L., Collins, R., et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 371 (2008), 117–125.
3. 3 Cholesterol Treatment Trialists' (CTT) Collaborators, Mihaylova, B., Emberson, J., Blackwell, L., et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 380 (2012), 581–590.
4. 4 Kashani, A., Phillips, C.O., Foody, J.M., et al. Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation 114 (2006), 2788–2797.
5. 5 Rosenson, R.S., Kent, S.T., Brown, T.M., et al. Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease. J Am Coll Cardiol 65 (2015), 270–277.
6. 6 Johansen, M.E., Green, L.A., Sen, A., Kircher, S., Richardson, C.R., Cardiovascular risk and statin use in the United States. Ann Fam Med 12 (2014), 215–223.
7. 7 Stark Casagrande, S., Fradkin, J.E., Saydah, S.H., Rust, K.F., Cowie, C.C., The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care 36 (2013), 2271–2279.
8. 8 Pande, R.L., Perlstein, T.S., Beckman, J.A., Creager, M.A., Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation 124 (2011), 17–23.
9. 9 Ovbiagele, B., Schwamm, L.H., Smith, E.E., et al. Recent nationwide trends in discharge statin treatment of hospitalized patients with stroke. Stroke 41 (2010), 1508–1513.
10. 10 Bhatt, D.L., Steg, P.G., Ohman, E.M., et al., REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295 (2006), 180–189.
11. 11 Maddox, T.M., Borden, W.B., Tang, F., et al. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry. J Am Coll Cardiol 64 (2014), 2183–2192.
12. 12 Stone, N.J., Robinson, J.G., Lichtenstein, A.H., et al., American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2889–2934.
13. 13 Jacobson, T.A., Ito, M.K., Maki, K.C., et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1—full report. J Clin Lipidol 9 (2015), 129–169.
14. 14 Eckel, R.H., Jakicic, J.M., Ard, J.D., et al., American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2960–2984.
15. 15 Pencina, M.J., Navar-Boggan, A.M., D'Agostino, R.B. Sr., et al. Application of new cholesterol guidelines to a population-based sample. N Engl J Med 370 (2014), 1422–1431.
16. 16 Available at: http://www.athero.org.au/fh/wp-content/uploads/Supporting-Documentation-for-the-manual-calculation-of-DLCNS.pdf. Accessed April 6, 2016.
17. 17 Goff, D.C. Jr., Lloyd-Jones, D.M., Bennett, G., et al., American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2935–2959.
18. 18 Levey, A.S., Stevens, L.A., Schmid, C.H., et al., CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 150 (2009), 604–612.
19. 19 Department of Health and Human Services Centers for Disease Control and Prevention. NHANES 2011-2012 Laboratory/Medical Technologists Procedure Manual. Hyattsville, MD: USA.
20. 20 Spinler, S.A., Cziraky, M.J., Willey, V.J., et al., NCDR. Frequency of attainment of low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol goals in cardiovascular clinical practice (from the National Cardiovascular Data Registry PINNACLE Registry). Am J Cardiol 116 (2015), 547–553.
21. 21 Tattersall, M.C., Gangnon, R.E., Karmali, K.N., Cullen, M.W., Stein, J.H., Keevil, J.G., Trends in low-density lipoprotein cholesterol goal achievement in high risk United States adults: longitudinal findings from the 1999-2008 National Health and Nutrition Examination Surveys. PLoS One, 8, 2013, e59309.
22. 22 Ho, P.M., Magid, D.J., Shetterly, S.M., et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J 155 (2008), 772–779.
23. 23 Bates, T.R., Connaughton, V.M., Watts, G.F., Non-adherence to statin therapy: a major challenge for preventive cardiology. Expert Opin Pharmacother 10 (2009), 2973–2985.
24. 24 Foody, J.M., Joyce, A.T., Rudolph, A.E., Liu, L.Z., Benner, J.S., Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study. Curr Med Res Opin 24 (2008), 1987–2000.
25. 25 Brookhart, M.A., Patrick, A.R., Schneeweiss, S., et al. Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use. Arch Intern Med 167 (2007), 847–852.
26. 26 Jacobson, T.A., Maki, K.C., Orringer, C.E., et al., NLA Expert Panel. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 2. J Clin Lipidol 9:6 Suppl (2015), S1–S122.e1.
27. 27 Lloyd-Jones, D.M., Morris, P.B., Ballantyne, C.M., et al. 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 68 (2016), 92–125.